Literature DB >> 6682697

Hyperthermia and thermal tolerance in normal and ataxia telangiectasia human cell strains.

G P Raaphorst, E I Azzam.   

Abstract

Three normal human fibroblast strains, two human ataxia telangiectasia heterozygote cell strains, and two human ataxia telangiectasia homozygote cell strains were studied for their thermal responses between 41.0 and 46.0 degrees. The heat sensitivities of all cell strains were comparable, and all cell strains were relatively heat resistant compared to Chinese hamster cells. Both normal and ataxia telangiectasia human cells developed thermal tolerance during heating at temperatures less than or equal to 43 degrees and during incubation at 37 degrees after acute heating at 45.0 degrees. For survival measured down to the 5 to 10% level, heat survival curves for all seven human cell strains lacked shoulders, indicating the inability of such cells to accumulate sublethal heat damage. Analysis of the cell survival curve data by the method of Arrhenius showed that the thermal inactivation energies for human cells were 127 and 230 kcal/mol above and below the break at 43.5 degrees, respectively, and are about the same as for Chinese hamster cells and other animal cells, implying similar mechanisms of heat inactivation.

Entities:  

Mesh:

Year:  1983        PMID: 6682697

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

Review 1.  Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect.

Authors:  P J McKinnon
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

2.  Magnetic Hyperthermia in Y79 Retinoblastoma and ARPE-19 Retinal Epithelial Cells: Tumor Selective Apoptotic Activity of Iron Oxide Nanoparticle.

Authors:  Hakan Demirci; Naziha Slimani; Mercy Pawar; Ronald E Kumon; Prem Vaishnava; Cagri G Besirli
Journal:  Transl Vis Sci Technol       Date:  2019-09-27       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.